Share prices of leading vaccine developers experienced significant gains on Tuesday following the announcement of America’s first human death from the H5 strain of bird flu. The market response saw
Share prices of leading vaccine developers experienced significant gains on Tuesday following the announcement of America’s first human death from the H5 strain of bird flu. The market response saw






